Whether qualified foreign institutional investors can effectively play a governance role in the capital market and guide the transformation of corporate innovation from “high-volume and low-quality” to “high-volume and high-quality” is an important issue in the process of foreign capital introduction at the present stage. From the perspective of how QFII shareholding affects the innovation model of firms, this study analyzes the data of China’s A-share listed companies from 2007 to 2018 and finds that the shareholding of qualified foreign institutional investors has significantly improved the innovation level of the invested firms, which is reflected in the increase of innovation output and the improvement of innovation quality. The mediating effect shows that QFII shareholding can improve the innovation level of corporates by slowing down insider tunneling of holding companies and increasing the number of analysts to follow, which indicates that QFII is conducive to improving the governance structure of listed companies and improving their qualities. Further research finds that QFII shareholding has a positive impact on corporate efficiency by improving the level of corporate innovation. The above conclusions provide experience and reference for China to further introduce foreign capital.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.